MBX MBX Biosciences, Inc. - Common Stock

NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗
$31.23
价格 · 五月 20, 2026
截至...的财报数据 五月 7, 2026
52周区间
$9–$46
60% of range
分析师评级
BUY
15 analysts
目标价
$69
+121% upside
P/E (TTM)
-13.3
ROE
-29.6%
净利润率
—

MBX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$31.23
市值
$1.42B
P/E (TTM)
-13.3
每股收益 (TTM)
$-2.38
营收 (TTM)
—
股息收益率
—
ROE
-29.6%
负债/权益
—
52周区间
$9 – $46

MBX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 —
EPS $-2.38
3-point trend, +92.6%
2023-12-31 → 2025-12-31
自由现金流 $-82M
2-point trend, -47.4%
2024-12-31 → 2025-12-31
利润率 —

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？

指标
5年趋势
MBX
同行中位数
P/E (TTM)
2-point trend, -318.5%
-13.3
22.4
P/B (市净率)
2-point trend, +60.4%
3.8
4.6
Price / FCF (股价/自由现金流)
2-point trend, -56.1%
-17.3
—

盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
MBX
同行中位数
ROA
2-point trend, +24.2%
-26.6%
-7.1%
ROE
2-point trend, -26.2%
-29.6%
-18.6%
ROIC
-26.6%
—

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
MBX
同行中位数
Current Ratio (流动比率)
2-point trend, +1.8%
24.6
3.9
Quick Ratio (速动比率)
2-point trend, +1.7%
24.1
—

成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
MBX
同行中位数

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
MBX
同行中位数
EPS (Diluted) (EPS (稀释))
3-point trend, +92.6%
$-2.38
—

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
MBX
同行中位数

MBX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 15 位分析师
  • 强烈买入 5 33.3%
  • 买入 8 53.3%
  • 持有 1 6.7%
  • 卖出 1 6.7%
  • 强烈卖出 0 0.0%

12个月价格目标

11 位分析师 · 2026-05-19
中位数目标 $70.00 +124.2%
平均目标 $69.09 +121.3%

收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期

平均惊喜
0.11%
期间 EPS Actual EPS 预期 惊喜
2026年3月31日 $-0.51 $-0.59 0.08%
2025年12月31日 $-0.49 $-0.62 0.13%
2025年9月30日 $-0.63 $-0.70 0.07%
2025年6月30日 $-0.58 $-0.77 0.19%
2025年3月31日 $-0.71 $-0.78 0.07%

同行比较 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
MBX $1.42B -13.3 — — -29.6% —
OCUL $2.62B -8.5 -18.5% -511.9% -55.4% —
RAPP $1.45B -10.6 — — -29.8% —
INVA — 6.1 14.7% — — —
NUVB $3.03B -14.9 699.0% -325.3% -60.3% —
ATAI $223M -1.4 -1.9% -48464.0% -83.1% —
AMLX $1.33B -7.9 -77.1% — -61.2% —
MAZE $2.04B -13.6 — — -598.9% —
PAHC — 21.5 27.4% 3.7% 17.8% 30.9%
SEPN $1.25B -25.3 4174.5% -106.4% -12.9% —

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 12
MBX 的年度损益表数据
指标 趋势 202520242023
R&D Expense 3-point trend, +177.4% $79M $57M $29M
SG&A Expense 3-point trend, +178.8% $19M $11M $7M
Operating Expenses 3-point trend, +177.7% $98M $68M $35M
Operating Income 3-point trend, -177.7% $-98M $-68M $-35M
Pretax Income 2-point trend, -40.5% $-87M $-62M ·
Income Tax Flat — no change across 3 periods $0 $0 $0
Net Income 3-point trend, -167.2% $-87M $-62M $-33M
EPS (Basic) 3-point trend, +92.6% $-2.38 $-5.82 $-31.96
EPS (Diluted) 3-point trend, +92.6% $-2.38 $-5.82 $-31.96
Shares (Basic) 3-point trend, +3483.4% 36,506,092 10,642,954 1,018,757
Shares (Diluted) 3-point trend, +3483.4% 36,506,092 10,642,954 1,018,757
EBITDA 2-point trend, -43.8% $-98M $-68M ·
资产负债表 21
MBX 的年度资产负债表数据
指标 趋势 202520242023
Cash & Equivalents 3-point trend, +146.7% $75M $49M $31M
Short-term Investments 3-point trend, +495.0% $298M $213M $50M
Prepaid Expense 3-point trend, +180.9% $8M $5M $3M
Other Current Assets 3-point trend, +547.4% $861.0K $803.0K $133.0K
Current Assets 3-point trend, +357.1% $382M $267M $83M
PP&E (Net) 3-point trend, +523.0% $3M $1M $439.0K
PP&E (Gross) 3-point trend, +451.9% $3M $2M $617.0K
Accum. Depreciation 3-point trend, +276.4% $670.0K $422.0K $178.0K
Other Non-current Assets 3-point trend, +666.0% $383.0K $50.0K $50.0K
Total Assets 3-point trend, +357.5% $385M $269M $84M
Accounts Payable 3-point trend, +114.0% $3M $5M $1M
Accrued Liabilities 3-point trend, +418.3% $12M $6M $2M
Current Liabilities 3-point trend, +294.7% $15M $11M $4M
Capital Leases 3-point trend, +148.0% $424.0K $0 $171.0K
Total Liabilities 3-point trend, +271.0% $16M $11M $4M
Common Stock 3-point trend, +500.0% $6.0K $5.0K $1.0K
Retained Earnings 3-point trend, -197.0% $-224M $-138M $-76M
AOCI 3-point trend, +376.7% $286.0K $55.0K $60.0K
Stockholders' Equity 3-point trend, +609.5% $369M $257M $-72M
Liabilities + Equity 3-point trend, +357.5% $385M $269M $84M
Shares Outstanding 3-point trend, +3474.0% 44,927,953 33,421,525 1,257,080
现金流 9
MBX 的年度现金流数据
指标 趋势 202520242023
Stock-based Comp 3-point trend, +324.7% $9M $5M $2M
Operating Cash Flow 3-point trend, -150.0% $-80M $-55M $-32M
CapEx 3-point trend, +1395.3% $2M $874.0K $129.0K
Investing Cash Flow 3-point trend, -170.7% $-84M $-161M $-31M
Stock Issued $602M · ·
Net Stock Activity $602M · ·
Financing Cash Flow 3-point trend, +173.9% $190M $234M $69M
Net Change in Cash 3-point trend, +310.9% $26M $19M $6M
Free Cash Flow 2-point trend, -47.4% $-82M $-56M ·
盈利能力 3
MBX 的年度盈利能力数据
指标 趋势 202520242023
ROA 2-point trend, +24.2% -26.6% -35.1% ·
ROE 2-point trend, -26.2% -29.6% -23.4% ·
ROIC -26.6% · ·
流动性与偿付能力 2
MBX 的年度流动性与偿付能力数据
指标 趋势 202520242023
Current Ratio 2-point trend, +1.8% 24.6 24.2 ·
Quick Ratio 2-point trend, +1.7% 24.1 23.7 ·
每股 4
MBX 的年度每股数据
指标 趋势 202520242023
Book Value / Share 2-point trend, +6.7% $8.22 $7.70 ·
Cash Flow / Share 2-point trend, +57.4% $-2.19 $-5.14 ·
Cash / Share 2-point trend, +13.5% $1.68 $1.48 ·
EPS (TTM) 2-point trend, +59.1% $-2.38 $-5.82 ·
估值 (TTM) 8
MBX 的年度估值 (TTM)数据
指标 趋势 202520242023
Net Income TTM 2-point trend, -40.5% $-87M $-62M ·
Market Cap 2-point trend, +130.1% $1.42B $616M ·
P/E 2-point trend, -318.5% -13.3 -3.2 ·
P/B 2-point trend, +60.4% 3.8 2.4 ·
P / Tangible Book 2-point trend, +60.4% 3.8 2.4 ·
P / Cash Flow 2-point trend, -57.3% -17.7 -11.3 ·
P / FCF 2-point trend, -56.1% -17.3 -11.1 ·
Earnings Yield 2-point trend, +76.1% -7.5% -31.6% ·

财务报表 损益表、资产负债表、现金流量表 — 年度，近5年

损益表
2025-12-312024-12-312023-12-31
净收入 $-87M$-62M$-33M
稀释后每股收益 (EPS) $-2.38$-5.82$-31.96
资产负债表
2025-12-312024-12-312023-12-31
流动比率 24.624.2—
速动比率 24.123.7—
现金流
2025-12-312024-12-312023-12-31
自由现金流 $-82M$-56M—

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存，并会跟随您浏览所有股票。